LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 81

Search options

  1. Article ; Online: Hematoma of the interatrial septum after surgery for a giant aneurysm of the sinus of Valsalva.

    Pacholewicz, Jerzy / Żych, Andrzej / Olędzki, Szymon / Płońska-Gościniak, Edyta

    Kardiologia polska

    2023  Volume 82, Issue 1, Page(s) 109–110

    MeSH term(s) Humans ; Sinus of Valsalva/diagnostic imaging ; Sinus of Valsalva/surgery ; Aortic Aneurysm/complications ; Aortic Aneurysm/diagnostic imaging ; Aortic Aneurysm/surgery ; Atrial Septum/diagnostic imaging ; Atrial Septum/surgery ; Hematoma/diagnostic imaging ; Hematoma/etiology ; Hematoma/surgery
    Language English
    Publishing date 2023-09-03
    Publishing country Poland
    Document type Journal Article
    ZDB-ID 411492-9
    ISSN 1897-4279 ; 0022-9032
    ISSN (online) 1897-4279
    ISSN 0022-9032
    DOI 10.33963/v.kp.96854
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Intracardiac pseudotumor: Caseous calcification of the mitral annulus on multimodality imaging.

    Olędzki, Szymon / Gościniak, Piotr / Żych, Andrzej / Peregud-Pogorzelska, Małgorzata / Płońska-Gościniak, Edyta

    Kardiologia polska

    2023  Volume 81, Issue 3, Page(s) 302–303

    MeSH term(s) Humans ; Mitral Valve/diagnostic imaging ; Mitral Valve/surgery ; Heart Valve Diseases/diagnostic imaging ; Heart Valve Diseases/surgery
    Language English
    Publishing date 2023-01-14
    Publishing country Poland
    Document type Journal Article
    ZDB-ID 411492-9
    ISSN 1897-4279 ; 0022-9032
    ISSN (online) 1897-4279
    ISSN 0022-9032
    DOI 10.33963/KP.a2023.0013
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article: Transesophageal echocardiography.

    Szyszka, Andrzej / Płońska-Gościniak, Edyta

    Journal of ultrasonography

    2019  Volume 19, Issue 76, Page(s) 62–65

    Abstract: Transthoracic and transesophageal examinations should be considered as mutually complementary. Transesophageal echocardiography is performed in cases of a justified need to visualize structures that are poorly visible or invisible on transthoracic ... ...

    Abstract Transthoracic and transesophageal examinations should be considered as mutually complementary. Transesophageal echocardiography is performed in cases of a justified need to visualize structures that are poorly visible or invisible on transthoracic echocardiogram. Primary indications for transesophageal echocardiography include an assessment of cardiac source of embolism, suspected endocarditis, suspected prosthetic valve dysfunction, an assessment of thoracic aorta and other vessels, an assessment prior to valvular repairs and closures of septal defects, intraoperative monitoring of cardiac or percutaneous interventions, ablation, non-diagnostic transthoracic examination, especially in patients after cardiac surgeries. Serious complications after transesophageal examination are very rare. This type of examination should not be performed in patients who consumed a meal 4-6 hours before the test, or when there is a risk of esophageal perforation and massive gastrointestinal bleeding. The test should be performed in an appropriately accredited laboratory and by a cardiologist with an individual accreditation. Transesophageal echocardiography may be performed in an outpatient setting. It should be recorded using the available media. The description should include comprehensive answers to questions in the referral. Transesophageal examination requires patient consent. It is performed using a multiplanar probe, which ensures the best conditions for imaging of the heart and the thoracic aorta. First of all, the reason for referral should be diagnosed. Depending on the setting depth, the following views may be distinguished: low transesophageal view (the probe is advanced approximately 30 cm from the teeth), mid transesophageal view (the probe is advanced approximately 30 cm from the teeth), high transesophageal view (the probe is advanced approximately 25-30 cm from the teeth), transgastric subcardiac view (the probe is advanced approximately 35-40 cm from the teeth), transgastric five-chamber view (the probe is advanced deeper than in the subcardiac view and with a stronger anterior flexion of the probe, aortic (the probe should be rotated at about 180°).
    Transthoracic and transesophageal examinations should be considered as mutually complementary. Transesophageal echocardiography is performed in cases of a justified need to visualize structures that are poorly visible or invisible on transthoracic echocardiogram. Primary indications for transesophageal echocardiography include an assessment of cardiac source of embolism, suspected endocarditis, suspected prosthetic valve dysfunction, an assessment of thoracic aorta and other vessels, an assessment prior to valvular repairs and closures of septal defects, intraoperative monitoring of cardiac or percutaneous interventions, ablation, non-diagnostic transthoracic examination, especially in patients after cardiac surgeries. Serious complications after transesophageal examination are very rare. This type of examination should not be performed in patients who consumed a meal 4–6 hours before the test, or when there is a risk of esophageal perforation and massive gastrointestinal bleeding. The test should be performed in an appropriately accredited laboratory and by a cardiologist with an individual accreditation. Transesophageal echocardiography may be performed in an outpatient setting. It should be recorded using the available media. The description should include comprehensive answers to questions in the referral. Transesophageal examination requires patient consent. It is performed using a multiplanar probe, which ensures the best conditions for imaging of the heart and the thoracic aorta. First of all, the reason for referral should be diagnosed. Depending on the setting depth, the following views may be distinguished: low transesophageal view (the probe is advanced approximately 30 cm from the teeth), mid transesophageal view (the probe is advanced approximately 30 cm from the teeth), high transesophageal view (the probe is advanced approximately 25–30 cm from the teeth), transgastric subcardiac view (the probe is advanced approximately 35–40 cm from the teeth), transgastric five-chamber view (the probe is advanced deeper than in the subcardiac view and with a stronger anterior flexion of the probe, aortic (the probe should be rotated at about 180°).
    Language English
    Publishing date 2019-07-06
    Publishing country Poland
    Document type Journal Article
    ZDB-ID 2843824-3
    ISSN 2084-8404
    ISSN 2084-8404
    DOI 10.15557/JoU.2019.0009
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: Cardiovascular Involvement in Patients with Autosomal Dominant Polycystic Kidney Disease: A Review.

    Pietrzak-Nowacka, Maria / Safranow, Krzysztof / Płońska-Gościniak, Edyta / Nowacki, Adam / Późniak, Piotr / Gutowski, Piotr / Ciechanowski, Kazimierz

    Kidney & blood pressure research

    2023  Volume 49, Issue 1, Page(s) 9–19

    Abstract: Background: Autosomal dominant polycystic kidney disease (ADPKD) is the most common hereditary kidney disease with a prevalence of 1:400 to 1:1,000 in Caucasians. It is caused by mutations in the PKD1 gene located on chromosome 16p13.3 (in about 85% ... ...

    Abstract Background: Autosomal dominant polycystic kidney disease (ADPKD) is the most common hereditary kidney disease with a prevalence of 1:400 to 1:1,000 in Caucasians. It is caused by mutations in the PKD1 gene located on chromosome 16p13.3 (in about 85% cases) as well as in the PKD2 gene on chromosome 4q13-23. In the Polish population, the disease is associated with PKD1 mutations in 84% of the ADPKD-affected families. PKD1 and PKD2 genes encode the proteins polycystin-1 (PC1) and polycystin-2 (PC2), respectively. The presence of kidney cysts is a characteristic feature in the ADPKD patients. But in the ADPKD patients, cardiovascular abnormalities, such as hypertension (HT) with higher systolic blood pressure (SBP) and diastolic blood pressure (DBP) values, higher left ventricular mass (LVM), intracranial (ICAN) and extracranial aneurysms, and cardiac valve defects, are significantly more common than in the general population.
    Summary: According to the literature data, both higher LVM and vascular dysfunction already occur in children and young adults with normal renal function and without HT. Moreover, biventricular diastolic dysfunction, endothelial dysfunction, increased carotid intima-media thickness, and impaired coronary flow velocity reserve are present even in young patients with ADPKD who have normal HT and well-preserved renal function. In patients with ADPKD, hypertension has some specific features; in the youngest age group of children, the prevalence of hypertension is greater if their parents suffer from hypertension; in normotensive young ADPKD-diagnosed individuals, ambulant SBP and DBP values were significantly higher than in age- and gender-matched controls; hypertension appears at least 10 years earlier than spontaneous HT in general population. In adults, HT is often diagnosed before any substantial reduction in the GFR, and a lower nocturnal dip in BP in comparison to hypertensives in the general population. PKD1 and PKD2 gene products (PC1 and PC2 proteins) have been shown to assemble at the plasma membrane and to regulate calcium (Ca2+) entry. A defect in Ca2+ binding mediated by mutations in polycystin proteins is a hypothetical factor contributing to left ventricular mass increase. Altered intracellular Ca2+ handling contributes importantly to impaired contractility associated with heart failure. Impairment of intracellular Ca2+ homeostasis and mitochondrial function has been implicated in the development of LVH.
    Key messages: It can be assumed that the cause of LVH in ADPKD patients is the natural course of this disease with developing HT and deteriorating kidney function, which may be influenced by the presence of PKD1- and PKD2-mutated gene products: PC1 and PC2 proteins.
    MeSH term(s) Child ; Young Adult ; Humans ; Polycystic Kidney, Autosomal Dominant/complications ; Polycystic Kidney, Autosomal Dominant/genetics ; TRPP Cation Channels/genetics ; Calcium/metabolism ; Carotid Intima-Media Thickness ; Hypertension/complications
    Chemical Substances TRPP Cation Channels ; Calcium (SY7Q814VUP)
    Language English
    Publishing date 2023-12-14
    Publishing country Switzerland
    Document type Journal Article ; Review
    ZDB-ID 1326018-2
    ISSN 1423-0143 ; 1420-4096
    ISSN (online) 1423-0143
    ISSN 1420-4096
    DOI 10.1159/000529119
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: Transesophageal echocardiography

    Andrzej Szyszka / Edyta Płońska-Gościniak

    Journal of Ultrasonography, Vol 19, Iss 76, Pp 62-

    2019  Volume 65

    Abstract: Transthoracic and transesophageal examinations should be considered as mutually complementary. Transesophageal echocardiography is performed in cases of a justified need to visualize structures that are poorly visible or invisible on transthoracic ... ...

    Abstract Transthoracic and transesophageal examinations should be considered as mutually complementary. Transesophageal echocardiography is performed in cases of a justified need to visualize structures that are poorly visible or invisible on transthoracic echocardiogram. Primary indications for transesophageal echocardiography include an assessment of cardiac source of embolism, suspected endocarditis, suspected prosthetic valve dysfunction, an assessment of thoracic aorta and other vessels, an assessment prior to valvular repairs and closures of septal defects, intraoperative monitoring of cardiac or percutaneous interventions, ablation, non-diagnostic transthoracic examination, especially in patients after cardiac surgeries. Serious complications after transesophageal examination are very rare. This type of examination should not be performed in patients who consumed a meal 4–6 hours before the test, or when there is a risk of esophageal perforation and massive gastrointestinal bleeding. The test should be performed in an appropriately accredited laboratory and by a cardiologist with an individual accreditation. Transesophageal echocardiography may be performed in an outpatient setting. It should be recorded using the available media. The description should include comprehensive answers to questions in the referral. Transesophageal examination requires patient consent. It is performed using a multiplanar probe, which ensures the best conditions for imaging of the heart and the thoracic aorta. First of all, the reason for referral should be diagnosed. Depending on the setting depth, the following views may be distinguished: low transesophageal view (the probe is advanced approximately 30 cm from the teeth), mid transesophageal view (the probe is advanced approximately 30 cm from the teeth), high transesophageal view (the probe is advanced approximately 25–30 cm from the teeth), transgastric subcardiac view (the probe is advanced approximately 35–40 cm from the teeth), transgastric five-chamber view (the probe is ...
    Keywords transesophageal echocardiography ; indications ; methodology ; views ; Medicine (General) ; R5-920 ; Medical technology ; R855-855.5
    Language English
    Publishing date 2019-03-01T00:00:00Z
    Publisher Sciendo
    Document type Article ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  6. Article ; Online: The importance of detection and percutaneous closure of patent foramen ovale during the coronavirus disease 2019 pandemic. Authors' reply.

    Kasprzak, Jarosław D / Płońska-Gościniak, Edyta / Bartuś, Stanisław / Gąsior, Zbigniew / Grygier, Marek

    Kardiologia polska

    2020  Volume 78, Issue 6, Page(s) 616–617

    MeSH term(s) Betacoronavirus ; COVID-19 ; Coronavirus ; Coronavirus Infections ; Echocardiography ; Expert Testimony ; Foramen Ovale, Patent ; Humans ; Pandemics ; Pneumonia, Viral ; Poland ; SARS-CoV-2
    Keywords covid19
    Language English
    Publishing date 2020-06-25
    Publishing country Poland
    Document type Journal Article ; Comment
    ZDB-ID 411492-9
    ISSN 1897-4279 ; 0022-9032
    ISSN (online) 1897-4279
    ISSN 0022-9032
    DOI 10.33963/KP.15458
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: Management of valvular heart disease in patients with cancer: Multidisciplinary team, cancer-therapy related cardiotoxicity, diagnosis, transcatheter intervention, and cardiac surgery. Expert opinion of the Association on Valvular Heart Disease, Association of Cardiovascular Interventions, and Working Group on Cardiac Surgery of the Polish Cardiac Society.

    Płońska-Gościniak, Edyta / Piotrowski, Grzegorz / Wojakowski, Wojciech / Gościniak, Piotr / Olszowska, Maria / Lesiak, Maciej / Klotzka, Aneta / Grygier, Marek / Deja, Marek / Kasprzak, Jarosław D / Kukulski, Tomasz / Kosmala, Wojciech / Suwalski, Piotr / Kolowca, Maciej / Widenka, Kazimierz / Hryniewiecki, Tomasz

    Kardiologia polska

    2023  Volume 81, Issue 1, Page(s) 82–101

    Abstract: The Association on Valvular Heart Disease, Association of Cardiovascular Interventions, and the Working Group on CardiacSurgery of the Polish Cardiac Society have released a position statement on risk factors, diagnosis, and management of patients with ... ...

    Abstract The Association on Valvular Heart Disease, Association of Cardiovascular Interventions, and the Working Group on CardiacSurgery of the Polish Cardiac Society have released a position statement on risk factors, diagnosis, and management of patients with cancer and valvular heart disease (VHD). VHD can occur in patients with cancer in several ways, for example, it can exist or be diagnosed before cancer treatment, after cancer treatment, be an incidental finding during imaging tests, endocarditis related to immunosuppression, prolonged intravenous catheter use, or combination treatment, and nonbacterial thrombotic endocarditis. It is recommended to employ close cardiac surveillance for patients at high risk of complications during and after cancer treatment and for cancer treatments that may be cardiotoxic to be discussed by a multidisciplinary team. Patients with cancer and pre-existing severe VHD should be managed according to the 2021 European Society of Cardiology (ESC) and European Association for Cardio-Thoracic Surgery (EACTS) guidelines for VHD management, taking into consideration cancer prognosis and patient preferences.
    MeSH term(s) Humans ; Poland ; Thoracic Surgery ; Cardiotoxicity ; Expert Testimony ; Heart Valve Diseases/diagnosis ; Heart Valve Diseases/surgery ; Cardiac Surgical Procedures ; Endocarditis ; Patient Care Team ; Neoplasms/complications
    Language English
    Publishing date 2023-01-15
    Publishing country Poland
    Document type Journal Article
    ZDB-ID 411492-9
    ISSN 1897-4279 ; 0022-9032
    ISSN (online) 1897-4279
    ISSN 0022-9032
    DOI 10.33963/KP.a2023.0023
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: Wristbands in Home-Based Rehabilitation-Validation of Heart Rate Measurement.

    Jachymek, Magdalena / Jachymek, Michał T / Kiedrowicz, Radosław M / Kaźmierczak, Jarosław / Płońska-Gościniak, Edyta / Peregud-Pogorzelska, Małgorzata

    Sensors (Basel, Switzerland)

    2021  Volume 22, Issue 1

    Abstract: The possibility of using a smartwatch as a rehabilitation tool to monitor patients' heart rates during exercise has gained the attention of many researchers. This study aimed to evaluate the accuracy and precision of the HR measurement performed by two ... ...

    Abstract The possibility of using a smartwatch as a rehabilitation tool to monitor patients' heart rates during exercise has gained the attention of many researchers. This study aimed to evaluate the accuracy and precision of the HR measurement performed by two wrist monitors: the Fitbit Charge 4 and the Xiaomi Mi Band 5. Thirty-one healthy volunteers were asked to perform a stress test on a treadmill. Their heart rates were recorded simultaneously by the wristbands and an electrocardiogram (ECG) at 1 min intervals. The mean absolute error percentage (MAPE), Lin's concordance correlation coefficient (LCCC), and Bland-Altman analysis were calculated to compare the precision and accuracy of heart rate measurements. The estimated validation criteria were MAPE < 10% and LCCC < 0.8. The overall MAPE and LCCC of the Fitbit were 10.19% (±11.79%) and 0.753 (95% CI: 0.717-0.785), respectively. The MAPE and LCCC of the Xiaomi were 6.89% (±9.75) and 0.903 (0.886-0.917), respectively. The precision and accuracy of both devices decreased with the increased exercise intensity. The accuracy of wearable wrist-worn heart rate monitors varies and depends on the intensity of training. Therefore, the decision to use such a device as a heart rate monitor during in-home rehabilitation should be made with caution.
    MeSH term(s) Exercise ; Exercise Test ; Fitness Trackers ; Heart Rate ; Heart Rate Determination ; Humans
    Language English
    Publishing date 2021-12-23
    Publishing country Switzerland
    Document type Journal Article
    ZDB-ID 2052857-7
    ISSN 1424-8220 ; 1424-8220
    ISSN (online) 1424-8220
    ISSN 1424-8220
    DOI 10.3390/s22010060
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: From heart to lung cancer.

    Olędzki, Szymon / Lewińska, Teresa / Witkiewicz, Iwona / Płońska-Gościniak, Edyta

    Kardiologia polska

    2016  Volume 74, Issue 9, Page(s) 1026

    MeSH term(s) Aged ; Biopsy, Needle ; Carcinoma, Small Cell/complications ; Carcinoma, Small Cell/diagnosis ; Carcinoma, Small Cell/secondary ; Dyspnea/etiology ; Echocardiography ; Female ; Humans ; Liver Neoplasms/diagnosis ; Liver Neoplasms/secondary ; Lung Neoplasms/complications ; Lung Neoplasms/diagnosis ; Lung Neoplasms/pathology
    Language English
    Publishing date 2016
    Publishing country Poland
    Document type Case Reports ; Journal Article
    ZDB-ID 411492-9
    ISSN 1897-4279 ; 0022-9032
    ISSN (online) 1897-4279
    ISSN 0022-9032
    DOI 10.5603/KP.2016.0122
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: Management of patients after heart valve interventions. Expert opinion of the Working Group on Valvular Heart Diseases, Working Group on Cardiac Surgery, and Association of Cardiovascular Interventions of the Polish Cardiac Society.

    Płońska-Gościniak, Edyta / Wojakowski, Wojciech / Kukulski, Tomasz / Gąsior, Zbigniew / Grygier, Marek / Mizia-Stec, Katarzyna / Hirnle, Tomasz / Olszowska, Maria / Tomkiewicz-Pająk, Lidia / Kasprzak, Jarosław D / Suwalski, Piotr / Komar, Monika / Bartuś, Stanisław / Pysz, Piotr / Mizia-Szubryt, Magdalena / Hryniewiecki, Tomasz T

    Kardiologia polska

    2022  Volume 80, Issue 3, Page(s) 386–402

    MeSH term(s) Cardiac Surgical Procedures ; Expert Testimony ; Heart Valve Diseases/surgery ; Heart Valves ; Humans ; Poland
    Language English
    Publishing date 2022-03-15
    Publishing country Poland
    Document type Journal Article
    ZDB-ID 411492-9
    ISSN 1897-4279 ; 0022-9032
    ISSN (online) 1897-4279
    ISSN 0022-9032
    DOI 10.33963/KP.a2022.0055
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top